Save time and get answers to complex questions with AI chat
When will a generic version of xiaflex be available?Complera manufacturer?What's the recommended schedule for lurbinectedin side effect checks?Mebendazole ingredients?Mobic injection patent oehringer ingelheim france?
See the DrugPatentWatch profile for Tyrvaya
Tyrvaya is available in a 0.7 mL single-dose nasal spray device [1]. Each box contains 12 such devices [1].
Tyrvaya is a prescription nasal spray that is used to treat the signs and symptoms of dry eye disease [1]. It works by activating the trigeminal nerve, which then stimulates natural tear production [1]. This stimulation leads to increased tear film secretion [1].
Tyrvaya is indicated for the treatment of the signs and symptoms of dry eye disease [1].
Information regarding the specific patent expiry for Tyrvaya is not publicly detailed in the provided text. However, DrugPatentWatch.com tracks patent information for pharmaceuticals, which may include Tyrvaya [2].
Oculis Pharma developed Tyrvaya, and it is manufactured by Horizon Therapeutics [1].
Other Questions About Tyrvaya :